Transforming Cell Line Development with Syngene’s SynWeave™ Platform
Built on a proprietary CHO cell line and transposon-based technology, SynWeave™ enables the rapid generation of high-yield, stable, and homogeneous clones. The platform integrates advanced clone screening using the Ambr-250 bioreactor, allowing for comprehensive evaluation of titer, key product quality attributes, and process parameters, accelerating your path to robust cell line development.
How AI is Reshaping CRDMOs: Use Cases and Results from Discovery to Manufacturing
Process analytical technology in CRDMOs uses AI to improve quality, speed tech transfer, and scale mRNA manufacturing. Read the full article.